For GLP-1 medications like semaglutide and tirzepatide, cost is often the biggest barrier to starting treatment, or staying on it long enough to see results
10.1038/nm.4232 54
Based on available data and mechanism of action, retatrutide appears most relevant for: People with significant obesity (BMI 35+) who want maximum weight reduction and haven't achieved their goals on semaglutide or tirzepatide People with type 2 diabetes who need both glycemic control and meaningful weight loss People who have plateaued on existing GLP-1 therapy and are wondering if a more powerful triple agonist would move the needle People focused on metabolic longevity , where reducing adiposity, improving insulin sensitivity, and lowering chronic inflammation are all high-priority goals If you're someone chasing a 5-10 lb cosmetic goal, retatrutide is probably overkill
Expert Guidance : Our team of medical experts will guide you through every step of your GLP-1 /GIP dual agonists treatment plan, ensuring you understand the process and feel supported throughout your journey
It might be because of fewer platelets made in the bone marrow, more platelets being removed, or because of spleen or liver issues
One of the important things to keep in mind when it comes to losing weight with Tirzepatide is making sure that you are eating 1200 calories a day, as eating less than this can still cause weight gain